NO168888C - Analogifremgangsmaate for fremstilling av nye, terapeutiskanvendbare tetrahydro- hhv. oktahydro-(3,4'-bi-2h-pyrrol)-2,2'-dioner - Google Patents
Analogifremgangsmaate for fremstilling av nye, terapeutiskanvendbare tetrahydro- hhv. oktahydro-(3,4'-bi-2h-pyrrol)-2,2'-dionerInfo
- Publication number
- NO168888C NO168888C NO860655A NO860655A NO168888C NO 168888 C NO168888 C NO 168888C NO 860655 A NO860655 A NO 860655A NO 860655 A NO860655 A NO 860655A NO 168888 C NO168888 C NO 168888C
- Authority
- NO
- Norway
- Prior art keywords
- lower alkyl
- radical
- hydroxy
- converted
- group
- Prior art date
Links
- 125000000217 alkyl group Chemical group 0.000 abstract 13
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 241000534944 Thia Species 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000004450 alkenylene group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000002431 hydrogen Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 230000001777 nootropic effect Effects 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/38—2-Pyrrolones
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Semiconductor Lasers (AREA)
- Pyrrole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Luminescent Compositions (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
- Electroluminescent Light Sources (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH82885 | 1985-02-22 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO860655L NO860655L (no) | 1986-08-25 |
| NO168888B NO168888B (no) | 1992-01-06 |
| NO168888C true NO168888C (no) | 1992-04-15 |
Family
ID=4196139
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO860655A NO168888C (no) | 1985-02-22 | 1986-02-21 | Analogifremgangsmaate for fremstilling av nye, terapeutiskanvendbare tetrahydro- hhv. oktahydro-(3,4'-bi-2h-pyrrol)-2,2'-dioner |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US4789674A (de) |
| EP (1) | EP0192255B1 (de) |
| JP (1) | JPH0610192B2 (de) |
| KR (1) | KR900000737B1 (de) |
| AT (1) | ATE55377T1 (de) |
| AU (1) | AU589945B2 (de) |
| CA (1) | CA1331756C (de) |
| DD (1) | DD246994A5 (de) |
| DE (1) | DE3673186D1 (de) |
| DK (1) | DK81686A (de) |
| ES (3) | ES8802492A1 (de) |
| FI (1) | FI83510C (de) |
| GR (1) | GR860487B (de) |
| HU (1) | HU194824B (de) |
| IE (1) | IE58274B1 (de) |
| NO (1) | NO168888C (de) |
| NZ (1) | NZ215255A (de) |
| PH (1) | PH25925A (de) |
| PT (1) | PT82060B (de) |
| ZA (1) | ZA861302B (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH666483A5 (de) * | 1985-01-16 | 1988-07-29 | Lonza Ag | Verfahren zur herstellung von thiotetronsaeure. |
| IL80071A0 (en) * | 1985-09-24 | 1986-12-31 | Lonza Ag | Pyrrolidine acetamide derivatives |
| HU195773B (en) * | 1985-09-24 | 1988-07-28 | Lonza Ag | Process for preparing alkyl esters of 4-alkoxy-3-pyrrolin-2-on-1-yl-acetic acid |
| CH668423A5 (de) * | 1986-06-19 | 1988-12-30 | Lonza Ag | Verfahren zur herstellung von 4-alkoxy-3-pyrrolin-2-onen. |
| CH668424A5 (de) * | 1986-06-26 | 1988-12-30 | Lonza Ag | 4-benzyloxy-3-pyrrolin-2-on-l-yl-acetamid, dessen herstellung und verwendung. |
| CH668422A5 (de) * | 1986-06-26 | 1988-12-30 | Lonza Ag | 4-benzyloxy-3-pyrrolin-2-on, dessen herstellung und verwendung zur synthese von tetramsaeure. |
| CH667655A5 (de) * | 1986-09-24 | 1988-10-31 | Lonza Ag | Verfahren zur herstellung von 4-alkoxy-2(5h)-thiophenonen. |
| CH670644A5 (de) * | 1986-12-18 | 1989-06-30 | Lonza Ag | |
| DE58909320D1 (de) * | 1988-09-06 | 1995-08-03 | Lonza Ag | Verfahren zur Herstellung von 5-Alkyltetramsäuren. |
| FI95034C (fi) * | 1989-03-15 | 1995-12-11 | Lonza Ag | Menetelmä 1,3-substituoidun tetrahydro-1H-tieno/3,4-d/-imidatsol-2(3H)-on-4-ylideenipentaanihappoesterin valmistamiseksi |
| US7419911B2 (en) * | 2003-11-10 | 2008-09-02 | Ekc Technology, Inc. | Compositions and methods for rapidly removing overfilled substrates |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1061755A (fr) * | 1951-02-28 | 1954-04-15 | Procédé pour l'obtention de corps à forme lactame | |
| GB1039113A (en) * | 1964-08-06 | 1966-08-17 | Ucb Sa | New n-substituted lactams |
| US4144246A (en) * | 1976-11-15 | 1979-03-13 | Parke, Davis & Company | Pyrrolidineacetic acid esters |
| JPS567765A (en) * | 1979-06-29 | 1981-01-27 | Yasumitsu Tamura | 4,4'-methylenebis-(1-substituted-3-phenylamino-5-oxo-3,4-dehydropiperidine) derivative |
-
1986
- 1986-02-17 FI FI860709A patent/FI83510C/fi not_active IP Right Cessation
- 1986-02-18 PH PH33427A patent/PH25925A/en unknown
- 1986-02-19 EP EP86102155A patent/EP0192255B1/de not_active Expired - Lifetime
- 1986-02-19 DE DE8686102155T patent/DE3673186D1/de not_active Expired - Lifetime
- 1986-02-19 AT AT86102155T patent/ATE55377T1/de not_active IP Right Cessation
- 1986-02-20 GR GR860487A patent/GR860487B/el unknown
- 1986-02-20 ES ES552229A patent/ES8802492A1/es not_active Expired
- 1986-02-20 PT PT82060A patent/PT82060B/pt not_active IP Right Cessation
- 1986-02-21 DD DD86287241A patent/DD246994A5/de not_active IP Right Cessation
- 1986-02-21 JP JP61035368A patent/JPH0610192B2/ja not_active Expired - Lifetime
- 1986-02-21 NZ NZ215255A patent/NZ215255A/xx unknown
- 1986-02-21 CA CA000502393A patent/CA1331756C/en not_active Expired - Fee Related
- 1986-02-21 HU HU86743A patent/HU194824B/hu not_active IP Right Cessation
- 1986-02-21 ZA ZA861302A patent/ZA861302B/xx unknown
- 1986-02-21 AU AU53880/86A patent/AU589945B2/en not_active Ceased
- 1986-02-21 DK DK81686A patent/DK81686A/da not_active Application Discontinuation
- 1986-02-21 KR KR1019860001227A patent/KR900000737B1/ko not_active Expired
- 1986-02-21 NO NO860655A patent/NO168888C/no unknown
- 1986-02-24 IE IE47886A patent/IE58274B1/en not_active IP Right Cessation
-
1987
- 1987-06-16 ES ES557605A patent/ES8802609A1/es not_active Expired
- 1987-06-16 ES ES557604A patent/ES8801916A1/es not_active Expired
- 1987-06-24 US US07/065,800 patent/US4789674A/en not_active Expired - Fee Related
- 1987-06-25 US US07/068,783 patent/US4758575A/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE50256T1 (de) | Hypoglycemische thiazolidinedione. | |
| MY101541A (en) | Indolizine derivatives, process for preparing them and the compositions containing them | |
| GB1069343A (en) | Propanolamine derivatives | |
| FI870421A0 (fi) | Analogiamenetelmä alkueläintenvastaisesti vaikuttavien 5,6-dihydro-2-(substituoitu fenyyli)-1,2,4-triatsiini-3,5(2H,4H)-dionijohdannaisten valmistamiseksi | |
| NO168888C (no) | Analogifremgangsmaate for fremstilling av nye, terapeutiskanvendbare tetrahydro- hhv. oktahydro-(3,4'-bi-2h-pyrrol)-2,2'-dioner | |
| EP0614661A3 (de) | Benzyliden- und Cinnamyliden-Malononitril-Derivate zur Hemmung der Proliferativen Prozesse in Säugetierzellen. | |
| GB1265165A (de) | ||
| CA1273942C (en) | Derivatives of imidazole, their preparation and utilisation, and pharmaceutical compositions containing these derivatives | |
| GB1268951A (en) | Phenoxy-amines | |
| ATE63541T1 (de) | N-phenylethylaminoalkyl-benzamide als antiarrhythmische mittel. | |
| ATE123487T1 (de) | Derivate der kaffeinsäure und sie enthaltende pharmazeutische zusammensetzungen. | |
| DE3778642D1 (de) | Therapeutikum zur behandlung von magengeschwueren. | |
| FR2100682B1 (de) | ||
| GB1468079A (en) | Ethanolamine derivatives | |
| GB1177145A (en) | Heterocyclic Allylic Amines | |
| GB1316333A (en) | Pyrimidyl-ureas their preparation and use as immunosuppresants and anti-viral agents | |
| NO166586C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cykloalka-(b)-pyrazolo(3,4-d)-pyrridin-3-on-derivater. | |
| GB1042199A (en) | Certain substituted ª-alkyl and ª-cycloalkylamino-propionamides | |
| GB1276942A (en) | Derivatives of chloramphenicol and thiamphenicol |